These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31172855)

  • 1. Trends in addiction treatment in Irish prisons using national surveillance data, 2009-2014.
    Cannon A; Nally F; Collins A; Fay R; Lyons S
    Int J Prison Health; 2019 Jun; 15(2):105-113. PubMed ID: 31172855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mental healthcare interfaces in a regional Irish prison.
    Gulati G; Otuokpaikhian K; Crowley M; Pradeep V; Meagher D; Dunne CP
    Int J Prison Health; 2019 Mar; 15(1):14-23. PubMed ID: 30827156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: demand reduction strategies.
    Dolan K; Rodas A; Bode A
    Int J Prison Health; 2015; 11(1):30-8. PubMed ID: 25751705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
    Kirwan A; Curtis M; Dietze P; Aitken C; Woods E; Walker S; Kinner S; Ogloff J; Butler T; Stoové M
    J Urban Health; 2019 Jun; 96(3):400-410. PubMed ID: 30989484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health needs and risky behaviours among inmates in the largest prison of eastern Nepal.
    Shrestha G; Mulmi R; Yadav DK; Baral D; Yadav BK; Chakravartty A; Pokharel PK; Sapkota N
    Int J Prison Health; 2018 Dec; 14(4):254-267. PubMed ID: 30468108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injecting drug use in prison: prevalence and implications for needle exchange policy.
    Wright NM; Tompkins CN; Farragher TM
    Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Senior Management Perspective on the Policy Debate of Needle and Syringe Exchange Program Provision in Irish Prisons.
    Rosalim JP
    J Correct Health Care; 2020 Jan; 26(1):27-35. PubMed ID: 31983260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socio-demographic characteristics as correlates of psychological distress.
    Okoro JN; Ezeonwuka CN; Onu JU
    Int J Prison Health; 2018 Sep; 14(3):210-219. PubMed ID: 30274561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of pharmacy services in Portuguese prisons: a national survey.
    Alexandra Monteiro Guerra L; Façanha da Cruz Fresco P
    Int J Prison Health; 2013; 9(4):187-95. PubMed ID: 25763454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of exercise referral as an intervention for Irish male prisoners presenting with mental health symptoms.
    O'Toole S; Maguire J; Murphy P
    Int J Prison Health; 2018 Jun; 14(2):109-123. PubMed ID: 29869583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of drugs in Australian prisons: supply reduction strategies.
    Dolan K; Rodas A
    Int J Prison Health; 2014; 10(2):111-7. PubMed ID: 25764074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health promotion and young prisoners: a European perspective.
    MacDonald M; Rabiee F; Weilandt C
    Int J Prison Health; 2013; 9(3):151-64. PubMed ID: 25764388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
    Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV
    BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.
    Tompkins CN
    Int J Prison Health; 2013; 9(2):68-81. PubMed ID: 25758439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to implementing throughcare for problematic drug users in European prisons.
    MacDonald M; Williams J; Kane D
    Int J Prison Health; 2012; 8(2):68-84. PubMed ID: 25758018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Addictions].
    Besson J; Grivel J; Tomei A; Zullino D; Thorens G; Castro E; Hachaichi M; Devaud Cornaz C; Dudzus M; Gothuey I
    Rev Med Suisse; 2017 Jan; 13(544-545):12-15. PubMed ID: 28703526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use in remand prisoners: a consecutive case study.
    Mason D; Birmingham L; Grubin D
    BMJ; 1997 Jul; 315(7099):18-21. PubMed ID: 9233320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative and end-of-life care in prisons: a content analysis of the literature.
    Maschi T; Marmo S; Han J
    Int J Prison Health; 2014; 10(3):172-97. PubMed ID: 25764177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Older and incarcerated: policy implications of aging prison populations.
    Psick Z; Simon J; Brown R; Ahalt C
    Int J Prison Health; 2017 Mar; 13(1):57-63. PubMed ID: 28299972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.